CTLA-4 (CD152) controls homeostasis and suppressive capacity of regulatory T cells in mice. Arthritis Rheum. 60 , 123–132 (2009). Article CAS Google Scholar ...
SAN DIEGO and SUZHOU, China - Adagene Inc. (NASDAQ: ADAG), a biotechnology firm with a market capitalization of $85 million ...
News Medical on MSN4d
Microbes in your gut could determine cancer treatment outcomesResearchers reveal that gut microbiota influence the effectiveness of immune checkpoint inhibitors (ICIs) in cancer treatment ...
ONC-392 targets CTLA-4 in a way that selectively eliminates tumor-infiltrating regulatory T cells without affecting peripheral T cell activation by a mechanism illustrated in Fig. 1. Compared with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback